The outcomes of Ir-192 brachytherapy in gynecological cancers are generally positive. Many patients experience significant tumor shrinkage and, in some cases, complete remission. The prognosis depends on various factors, including the stage of the cancer, the patient's overall health, and how well the tumor responds to treatment.
